Desert Oasis Healthcare Recognized With ‘Best of the Desert’ Honors

March 24, 2026 10:00 AM

Desert Oasis Healthcare (DOHC) is proud to announce its recognition in the 2026 Palm Springs Community's Choice Awards, earning top honors and multiple finalist distinctions across several key healthcare categories. These awards reflect the trust and support of the community and reinforce DOHC's commitment to delivering high-quality, patient-centered care throughout the Coachella Valley. DOHC was named Winner for Home Health Care Services,...

Read more

Tivic Health CEO Letter to Shareholders

March 24, 2026 9:30 AM

Tivic Health Systems (Nasdaq:TIVC)Dear Valued Shareholders,As I assume the role of Chief Executive Officer at Tivic, my immediate priority is to establish a transparent dialogue with you regarding our current standing, our strategic pivot, and the long-term vision we are executing.First, I want to thank the Board of Directors for their confidence and support. Some of you recognize me from my time as Chief Executive Officer of Statera Biopharma,...

Read more

Taiwan's MedTech Ecosystem Attracts Global Interest Ahead of Medical Taiwan 2026

March 24, 2026 9:30 AM

As healthcare systems worldwide accelerate digital transformation, international buyers and healthcare providers are increasingly seeking reliable partners capable of delivering innovative medical technologies, integrated digital solutions, and resilient supply chains. In recent years, Taiwan has emerged as an important hub for medical technology development and manufacturing in Asia. Combining strong electronics manufacturing capabilities with...

Read more

REMINDER: Revelation Biosciences to Host Fireside Chat at 38th Annual Roth Conference

March 24, 2026 9:00 AM

Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company focused on rebalancing inflammation to optimize health, today announced a reminder of its participation in a fireside chat on Tuesday, March 24, 2026, at 2:00 p.m. PT, as part of the 38th Annual Roth Conference, in Dana Point, CA.The fireside chat will be webcast live here and available on our Investors section of the Revelation...

Read more

Altamira Therapeutics Announces Release Date for 2025 Annual Report and Financial Statements

March 24, 2026 9:00 AM

Altamira Therapeutics ("Altamira" or the "Company") (OTCID:CYTOF) today announced that it will release its annual report and financial statements for the fiscal year ended December 31, 2025 on March 31, 2026 at 9 am EDT.About Altamira TherapeuticsAltamira Therapeutics is developing and supplying peptide-based nanoparticle technologies for efficient nucleic acid delivery (xPhore™ platform). The versatile delivery platform is suited for different...

Read more

Sonoma Pharmaceuticals Announces U.S. Retail Launch of Advanced Burn Relief Hydrogel in CVS and Walmart

March 24, 2026 8:30 AM

Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader in hypochlorous acid (HOCl) technology, today announced the U.S. retail launch of its advanced HOCl-based burn relief hydrogel in CVS and Walmart stores nationwide.The hydrogel is indicated for the management of minor burns and skin irritations. Its gentle, non-irritating formulation is designed to help soothe damaged skin and support the natural healing process, making it...

Read more

InteliChart Named No. 1 in Black Book Research's 2026 Independent End-to-End Patient Engagement Solutions Rankings

March 24, 2026 8:00 AM

Black Book Research today announced that InteliChart has been ranked the No. 1 overall independent end-to-end patient engagement solution in its 2026 competitive performance evaluation of non-EHR-native platforms, based on validated provider-side client feedback from hospitals, health systems, medical groups, and other healthcare delivery organizations.In the 2026 rankings, InteliChart achieved the highest overall mean score of 9.55, earned 17...

Read more

KIFFIK Biomedical and HekaBio Announce Strategic Alliance to Expand ISF-Based Molecular Access Across Asia-Pacific

March 24, 2026 8:00 AM

KIFFIK Biomedical today announced a strategic alliance with HekaBio K.K. to expand access to interstitial fluid (ISF) across Japan and key Asia-Pacific markets.ISF surrounds living cells and reflects real-time biological activity at the tissue level - where molecular signaling, immune response, and disease progression originate. KIFFIK's K-EXP™ platform is designed to access molecular signals directly from interstitial fluid - before dilution in...

Read more

Vheda Health Ranked #10 on Fast Company's 2026 Most Innovative Companies List

March 24, 2026 7:30 AM

Vheda Health has been named to Fast Company's 2026 list of the World's Most Innovative Companies, landing at No. 10 in the Healthcare category. This year's list shines a spotlight on businesses that are shaping industry and culture through their innovations. Alongside the World's 50 Most Innovative Companies, Fast Company recognizes 720 honorees across 59 sectors and regions.This award celebrates the story of a vision that began in 2013, focused...

Read more

BioNxt Enters Commercialization Phase with Global Patent Protection and U.S. Fast Track Strategy for Sublingual Drug Delivery Platform

March 24, 2026 5:10 AM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to announce a major advancement in its commercialization strategy, supported by a rapidly expanding global patent portfolio for its proprietary sublingual drug delivery platform.BioNxt has established a broad and defensible intellectual property position across key global markets,...

Read more

Spago Nanomedical's Abstract on Tumorad(R) Accepted for Presentation at Radiopharma Conference

March 24, 2026 3:20 AM

Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) - Spago Nanomedical AB (publ) today announced that an abstract describing the ongoing Phase I/IIa clinical study Tumorad-01 with the radiopharmaceutical drug candidate 177Lu-SN201 has been accepted for presentation at the 56th Annual Scientific Meeting of the Australian and New Zealand Society of Nuclear Medicine (ANZSNM) to be held in Canberra on 15-17 May, 2026.The submitted abstract was accepted to...

Read more

Unprecedented Coalition of Athletes and Physicians Launches Utah's First Health Club to Guarantee Measurable Results

March 23, 2026 6:25 PM

Built by NFL athletes, surgeons, and performance scientists, ALYZE opens in Bountiful as Utah's first fully integrated luxury health club, functional medicine clinic, and longevity center - combining diagnostics, hormone optimization, weight loss programs, and recovery under one roof with guaranteed measurable progress. ALYZE, a next-generation health optimization clinic, luxury gym, and wellness center, announced today that its flagship...

Read more

Black Book Research Releases New 2026 Payer IT Series Report on the Medicaid-to-Medicare Transition Tech Stack

March 23, 2026 10:10 AM

Black Book Research today announced the release of The Medicaid-to-Medicare Transition Tech Stack, a new report in its 2026 Payer IT Software and Services Series examining how health plans manage one of the most operationally fragile moments in the member journey: the transition from Medicaid into Medicare. Based on payer-user feedback collected from Q4 2025 through Q1 2026, the study evaluates where transitions fail, which technologies matter...

Read more

Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders

March 23, 2026 9:05 AM

Wellgistics Health, Inc. ("Wellgistics" or the "Company") (NASDAQ:WGRX) today announced that it has entered into a non-exclusive, non-binding Letter of Intent ("LOI") to evaluate a potential acquisition of Neuritek Therapeutics, a neuroscience-focused research organization.The proposed all stock transaction, if completed, is intended to enhance Wellgistics' existing revenue-generating healthcare platform by expanding capabilities adjacent to its...

Read more

MIRA Pharmaceuticals Reports Mira-55 Shows No THC- or Rimonabant-Associated CNS Side Effects in Preclinical Studies

March 23, 2026 9:00 AM

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) ("MIRA" or the "Company"), a clinical-stage pharmaceutical company developing novel therapies for neurologic, neuropsychiatric, and metabolic disorders, today announced new preclinical data demonstrating that Mira-55 did not produce cannabinoid-like central nervous system (CNS) side effects across a comprehensive battery of validated behavioral assays. The observed profile was differentiated from both...

Read more

Medical Component Specialists Expands Global Footprint with New State-of-the-Art Manufacturing Facility in Costa Rica

March 23, 2026 9:00 AM

Medical Component Specialists (MCS) announced its expansion into Costa Rica's thriving medical device sector with the launch of a new state-of-the-art manufacturing facility, opening this summer. The move positions MCS within one of the world's fastest-growing medtech hubs and reinforces the company's commitment to delivering advanced manufacturing solutions to global partners. Following decades of sustained growth, medical devices became Costa...

Read more

Med-X to Showcase Nature-Cide at AMCA's 92nd Annual Meeting

March 23, 2026 8:31 AM

Med-X, Inc. ("Med-X" or the "Company") (Nasdaq:MXRX), a leading innovator in all-natural pest control solutions, today announced that its flagship Nature-Cide® product line will be featured at the American Mosquito Control Association's (AMCA) 92nd Annual Meeting, taking place March 23-27, 2026, at the Oregon Convention Center in Portland, Oregon. Attendees are invited to visit Nature-Cide at Booth 214 to explore the Company's full portfolio of...

Read more

Early Diagnosis and Local Solutions Are Critical To Combat Lung Cancer

March 23, 2026 8:30 AM

Opinion: Despite advances in prevention and treatment, lung cancer remains the world's deadliest cancer largely because it is often detected too late. Strengthening local diagnostic capacity is one of the most effective ways to reduce the global burden of lung cancer.Originally published on Devex.comBy Catharine Grimes, Raymond Osarogiagbon // 16 March 2026Lung cancer remains the leading cause of cancer death worldwide. According to the World...

Read more

Restoring Strength and Energy: How Luna Acupuncture & Wellness Supports Chemotherapy Patients on the Road to Recovery

March 22, 2026 1:55 PM

For many cancer patients, chemotherapy represents both a life-saving treatment and a difficult physical journey. While chemotherapy plays a critical role in fighting cancer, the process often brings side effects that can linger long after treatment sessions end. Fatigue, nausea, pain, sleep disruption, and emotional stress frequently affect patients during and after chemotherapy. In Oregon, Luna Acupuncture & Wellness is helping patients manage...

Read more

Tivic To Report 2025 Year-End Financial Results Via Conference Call and Webcast on March 25th at 1:30pm PT / 4:30pm ET

March 20, 2026 3:35 PM

Tivic Health Systems, Inc. (Nasdaq:TIVC), a late-stage immunotherapeutics company, today announced that it will report its year-end financial results for 2025 via pre-recorded conference call and webcast on Wednesday, March 25, 2026 at 1:30 PM PT / 4:30 PM ET.Conference Call and Webcast InformationTeleconference Details:Toll Free: 888-506-0062International: 973-528-0011Participant Access Code: 910220Webcast...

Read more